Wu L - Search Results

1

Integrin Alpha-2 as a Potential Prognostic and Predictive Biomarker for Patients With Lower-Grade Glioma.

Lin L, Huang K, Tu Z, Zhu X, Li J, Lei K, Luo M, Wang P, Gong C, Long X, Wu L. Lin L, et al. Among authors: wu l. Front Oncol. 2021 Oct 27;11:738651. doi: 10.3389/fonc.2021.738651. eCollection 2021. Front Oncol. 2021. PMID: 34778054 Free PMC article.

2

Transcriptional Patterns of Lower-Grade Glioma Patients with Distinct Ferroptosis Levels, Immunotherapy Response, and Temozolomide Sensitivity.

Tu Z, Li J, Long X, Wu L, Zhu X, Huang K. Tu Z, et al. Among authors: wu l. Oxid Med Cell Longev. 2022 May 10;2022:9408886. doi: 10.1155/2022/9408886. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 35592529 Free PMC article.

3

Development and validation of a leukocyte-associated immunoglobulin-like receptor-1 prognostic signature for lower-grade gliomas.

Fang Z, Lin L, Tu Z, Zhu X, Li J, Luo P, Huang K, Wu L. Fang Z, et al. Among authors: wu l. Cancer Med. 2023 Jan;12(1):712-732. doi: 10.1002/cam4.4945. Epub 2022 Jun 15. Cancer Med. 2023. PMID: 35702880 Free PMC article.

4

N6-Methylandenosine-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Lower-Grade Glioma Patients.

Tu Z, Wu L, Wang P, Hu Q, Tao C, Li K, Huang K, Zhu X. Tu Z, et al. Among authors: wu l. Front Cell Dev Biol. 2020 Jul 23;8:642. doi: 10.3389/fcell.2020.00642. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32793593 Free PMC article.

5

A Novel Signature Constructed by RNA-Binding Protein Coding Genes to Improve Overall Survival Prediction of Glioma Patients.

Tu Z, Shu L, Li J, Wu L, Tao C, Ye M, Zhu X, Huang K. Tu Z, et al. Among authors: wu l. Front Cell Dev Biol. 2021 Jan 28;8:588368. doi: 10.3389/fcell.2020.588368. eCollection 2020. Front Cell Dev Biol. 2021. PMID: 33634092 Free PMC article.

6

Systematic and Multi-Omics Prognostic Analysis of Lysine Acetylation Regulators in Glioma.

Tu Z, Wu L, Luo H, Li J, Lv S, Ye M, Liu F, Tao C, Zhu X, Huang K. Tu Z, et al. Among authors: wu l. Front Mol Biosci. 2021 Feb 26;8:587516. doi: 10.3389/fmolb.2021.587516. eCollection 2021. Front Mol Biosci. 2021. PMID: 33718432 Free PMC article.

7

Protein Disulfide-Isomerase A3 Is a Robust Prognostic Biomarker for Cancers and Predicts the Immunotherapy Response Effectively.

Tu Z, Ouyang Q, Long X, Wu L, Li J, Zhu X, Huang K. Tu Z, et al. Among authors: wu l. Front Immunol. 2022 Mar 25;13:837512. doi: 10.3389/fimmu.2022.837512. eCollection 2022. Front Immunol. 2022. PMID: 35401558 Free PMC article.

8

Sperm Autoantigenic Protein 17 Predicts the Prognosis and the Immunotherapy Response of Cancers: A Pan-Cancer Analysis.

Tu Z, Peng J, Long X, Li J, Wu L, Huang K, Zhu X. Tu Z, et al. Among authors: wu l. Front Immunol. 2022 May 3;13:844736. doi: 10.3389/fimmu.2022.844736. eCollection 2022. Front Immunol. 2022. PMID: 35592314 Free PMC article.

9

Intrinsic immune evasion patterns predict temozolomide sensitivity and immunotherapy response in lower-grade gliomas.

Tu Z, Ji Q, Han Q, Long X, Li J, Wu L, Huang K, Zhu X. Tu Z, et al. Among authors: wu l. BMC Cancer. 2022 Sep 12;22(1):973. doi: 10.1186/s12885-022-09984-5. BMC Cancer. 2022. PMID: 36096781 Free PMC article.

10

MicroRNA-375 inhibits glioma cell proliferation and migration by downregulating RWDD3 in vitro.

Ji CX, Fan YH, Xu F, Lv SG, Ye MH, Wu MJ, Zhu XG, Wu L. Ji CX, et al. Among authors: wu mj, wu l. Oncol Rep. 2018 Apr;39(4):1825-1834. doi: 10.3892/or.2018.6261. Epub 2018 Feb 13. Oncol Rep. 2018. Retraction in: Oncol Rep. 2020 Dec;44(6):2792. doi: 10.3892/or.2020.7785 PMID: 29436665 Retracted.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33,197 results

Search Page

Filters